Bionanotechnology and the future of glioma

Peter Chiarelli, Forrest Kievit, Miqin Zhang, Richard Ellenbogen

Research output: Contribution to journalReview article

15 Citations (Scopus)

Abstract

Designer nanoscaled materials have the potential to revolutionize diagnosis and treatment for glioma. This review summarizes current progress in nanoparticle-based therapies for glioma treatment including targeting, drug delivery, gene delivery, and direct tumor ablation. Preclinical and current human clinical trials are discussed. Although progress in the field has been significant over the past decade, many successful strategies demonstrated in the laboratory have yet to be implemented in human clinical trials. Looking forward, we provide examples of combined treatment strategies, which harness the potential for nanoparticles to interact with their biochemical environment, and simultaneously with externally applied photons or magnetic fields. We present our notion of the "ideal" nanoparticle for glioma, a concept that may soon be realized.

Original languageEnglish (US)
Pages (from-to)S45-S58
JournalSurgical Neurology International
Volume6
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Glioma
Nanoparticles
Clinical Trials
Magnetic Fields
Therapeutics
Drug Delivery Systems
Photons
Genes
Neoplasms

Keywords

  • Drug delivery
  • Glioblastoma multiforme
  • Nanomedicine
  • Nanoparticle
  • Nanotechnology
  • Theranostic

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Bionanotechnology and the future of glioma. / Chiarelli, Peter; Kievit, Forrest; Zhang, Miqin; Ellenbogen, Richard.

In: Surgical Neurology International, Vol. 6, No. 2, 01.01.2015, p. S45-S58.

Research output: Contribution to journalReview article

Chiarelli, Peter ; Kievit, Forrest ; Zhang, Miqin ; Ellenbogen, Richard. / Bionanotechnology and the future of glioma. In: Surgical Neurology International. 2015 ; Vol. 6, No. 2. pp. S45-S58.
@article{63ad569158b244cb8346d08a0afb3449,
title = "Bionanotechnology and the future of glioma",
abstract = "Designer nanoscaled materials have the potential to revolutionize diagnosis and treatment for glioma. This review summarizes current progress in nanoparticle-based therapies for glioma treatment including targeting, drug delivery, gene delivery, and direct tumor ablation. Preclinical and current human clinical trials are discussed. Although progress in the field has been significant over the past decade, many successful strategies demonstrated in the laboratory have yet to be implemented in human clinical trials. Looking forward, we provide examples of combined treatment strategies, which harness the potential for nanoparticles to interact with their biochemical environment, and simultaneously with externally applied photons or magnetic fields. We present our notion of the {"}ideal{"} nanoparticle for glioma, a concept that may soon be realized.",
keywords = "Drug delivery, Glioblastoma multiforme, Nanomedicine, Nanoparticle, Nanotechnology, Theranostic",
author = "Peter Chiarelli and Forrest Kievit and Miqin Zhang and Richard Ellenbogen",
year = "2015",
month = "1",
day = "1",
doi = "10.4103/2152-7806.151334",
language = "English (US)",
volume = "6",
pages = "S45--S58",
journal = "Surgical Neurology International",
issn = "2152-7806",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

TY - JOUR

T1 - Bionanotechnology and the future of glioma

AU - Chiarelli, Peter

AU - Kievit, Forrest

AU - Zhang, Miqin

AU - Ellenbogen, Richard

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Designer nanoscaled materials have the potential to revolutionize diagnosis and treatment for glioma. This review summarizes current progress in nanoparticle-based therapies for glioma treatment including targeting, drug delivery, gene delivery, and direct tumor ablation. Preclinical and current human clinical trials are discussed. Although progress in the field has been significant over the past decade, many successful strategies demonstrated in the laboratory have yet to be implemented in human clinical trials. Looking forward, we provide examples of combined treatment strategies, which harness the potential for nanoparticles to interact with their biochemical environment, and simultaneously with externally applied photons or magnetic fields. We present our notion of the "ideal" nanoparticle for glioma, a concept that may soon be realized.

AB - Designer nanoscaled materials have the potential to revolutionize diagnosis and treatment for glioma. This review summarizes current progress in nanoparticle-based therapies for glioma treatment including targeting, drug delivery, gene delivery, and direct tumor ablation. Preclinical and current human clinical trials are discussed. Although progress in the field has been significant over the past decade, many successful strategies demonstrated in the laboratory have yet to be implemented in human clinical trials. Looking forward, we provide examples of combined treatment strategies, which harness the potential for nanoparticles to interact with their biochemical environment, and simultaneously with externally applied photons or magnetic fields. We present our notion of the "ideal" nanoparticle for glioma, a concept that may soon be realized.

KW - Drug delivery

KW - Glioblastoma multiforme

KW - Nanomedicine

KW - Nanoparticle

KW - Nanotechnology

KW - Theranostic

UR - http://www.scopus.com/inward/record.url?scp=84930385752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930385752&partnerID=8YFLogxK

U2 - 10.4103/2152-7806.151334

DO - 10.4103/2152-7806.151334

M3 - Review article

C2 - 25722933

AN - SCOPUS:84930385752

VL - 6

SP - S45-S58

JO - Surgical Neurology International

JF - Surgical Neurology International

SN - 2152-7806

IS - 2

ER -